It reduces NRF2 protein levels, downregulates NRF2 target gene expression, and inhibits tumorigenesis in KEAP1Mut and NRF2Mut lung cancer cells in vitro and in vivo. This evidence concerns the gene NFE2L2 and lung carcinoma.